Skip to main content

Table 3 Meta-regression model with 30-day mortality as outcome for conventional and goal-directed fluid therapy

From: Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression

Variable

CFM

GDT

Targeting urine output

0.74 (0.39-1.38)

1.17 (0.54-2.56)

Intensive Care setting (reference)

Intraoperative setting

0.15 (0.08-0.28)

0.12 (0.05-0.28)

Postoperative setting

0.06 (0.02-0.15)

0.12 (0.03-0.51)

Transpulmonary thermodilution (reference)

Esophageal Doppler

 

0.67 (0.21-2.11)

Pulmonary artery catheter

 

1.27 (0.25-6.35)

Other monitoring devices

 

0.79 (0.27-2.27)

Other etiologies (reference)

Abdominal

0.32 (0.15-0.69)

0.76 (0.32-1.77)

High risk

2.13 (0.94-4.81)

2.19 (0.74-6.51)

Inotropic use

1.40 (0.72-2.69)

1.01 (0.40-2.53)

Publication year a

0.97 (0.93-1.02)

1.00 (0.91-1.10)

  1. aPublication year was inputted as the years from the mean publication year (2008)
  2. Data reported as odds ratio and 95% confidence interval